These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30826456)

  • 1. Targeting the crosstalks of Wnt pathway with Hedgehog and Notch for cancer therapy.
    Chatterjee S; Sil PC
    Pharmacol Res; 2019 Apr; 142():251-261. PubMed ID: 30826456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles for Manipulation of the Developmental Wnt, Hedgehog, and Notch Signaling Pathways in Cancer.
    Valcourt DM; Dang MN; Wang J; Day ES
    Ann Biomed Eng; 2020 Jul; 48(7):1864-1884. PubMed ID: 31686312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
    Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
    Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer stem cells and targeted therapy.
    Keyvani V; Farshchian M; Esmaeili SA; Yari H; Moghbeli M; Nezhad SK; Abbaszadegan MR
    J Ovarian Res; 2019 Dec; 12(1):120. PubMed ID: 31810474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex crosstalk of Notch and Hedgehog signalling during the development of the central nervous system.
    Jacobs CT; Huang P
    Cell Mol Life Sci; 2021 Jan; 78(2):635-644. PubMed ID: 32880661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch inhibitors for cancer treatment.
    Espinoza I; Miele L
    Pharmacol Ther; 2013 Aug; 139(2):95-110. PubMed ID: 23458608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embryonic stem cell pathways and chemotherapy response: an unexplored route.
    Duhagon MA; Crea F; Danesi R; Farrar WL
    Ann Oncol; 2013 Feb; 24(2):558-559. PubMed ID: 23233652
    [No Abstract]   [Full Text] [Related]  

  • 8. Stem cells as therapeutic targets in colorectal cancer.
    Zalewski A; Snook AE; Waldman SA
    Per Med; 2021 Mar; 18(2):171-183. PubMed ID: 33565332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of hedgehog signaling in advanced cancer types.
    Singh R; Ray A
    Int Rev Cell Mol Biol; 2024; 386():49-80. PubMed ID: 38782501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the hedgehog pathway in MET mutation cancers and its effects on cells associated with cancer development.
    Du Y; Sun H; Shi Z; Sui X; Liu B; Zheng Z; Liu Y; Xuan Z; Zhong M; Fu M; Bai Y; Zhang Q; Shao C
    Cell Commun Signal; 2023 Nov; 21(1):313. PubMed ID: 37919751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition.
    Espinoza I; Pochampally R; Xing F; Watabe K; Miele L
    Onco Targets Ther; 2013 Sep; 6():1249-59. PubMed ID: 24043949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications.
    Patni AP; Harishankar MK; Joseph JP; Sreeshma B; Jayaraj R; Devi A
    Cell Oncol (Dordr); 2021 Jun; 44(3):473-494. PubMed ID: 33704672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
    Clara JA; Monge C; Yang Y; Takebe N
    Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beauvericin Reverses Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through Regulation of Notch Signaling and Autophagy.
    Patra A; Arora A; Ghosh SS; Kaur Saini G
    ACS Pharmacol Transl Sci; 2024 Sep; 7(9):2878-2893. PubMed ID: 39296261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies.
    Shi Q; Xue C; Zeng Y; Yuan X; Chu Q; Jiang S; Wang J; Zhang Y; Zhu D; Li L
    Signal Transduct Target Ther; 2024 May; 9(1):128. PubMed ID: 38797752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasticity and resistance of cancer stem cells as a challenge for innovative anticancer therapies - do we know enough to overcome this?
    Knopik-Skrocka A; Sempowicz A; Piwocka O
    EXCLI J; 2024; 23():335-355. PubMed ID: 38655094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment.
    Williams CH; Neitzel LR; Cornell J; Rea S; Mills I; Silver MS; Ahmad JD; Birukov KG; Birukova A; Brem H; Tyler B; Bar EE; Hong CC
    Exp Hematol Oncol; 2024 Jan; 13(1):13. PubMed ID: 38291540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets.
    Zhang M; Liu Q; Meng H; Duan H; Liu X; Wu J; Gao F; Wang S; Tan R; Yuan J
    Signal Transduct Target Ther; 2024 Jan; 9(1):12. PubMed ID: 38185705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of tumor resistance to radiotherapy.
    Wu Y; Song Y; Wang R; Wang T
    Mol Cancer; 2023 Jun; 22(1):96. PubMed ID: 37322433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.